Cargando…

Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study

To investigate whether cerebrospinal fluid (CSF) markers differ between pediatric-onset multiple sclerosis (PoMS, onset < 18 years) and adult-onset (AoMS), and whether these markers are associated with clinical outcomes among PoMS. Prospective nationwide registry study of incident MS, including p...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKay, Kyla A., Wickström, Ronny, Hillert, Jan, Karrenbauer, Virginija Danylaite
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448868/ https://www.ncbi.nlm.nih.gov/pubmed/34535701 http://dx.doi.org/10.1038/s41598-021-97543-6

Ejemplares similares

Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
por: Karrenbauer, Virginija Danylaité, et al.
Publicado: (2021)

Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function
por: Kavaliunas, Andrius, et al.
Publicado: (2022)

Income in Multiple Sclerosis Patients with Different Disease Phenotypes
por: Kavaliunas, Andrius, et al.
Publicado: (2017)

Cognitive function predicts work disability among multiple sclerosis patients
por: Kavaliunas, Andrius, et al.
Publicado: (2019)

Long-term disability progression of pediatric-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2019)

Syndrome of Transient Headache and Neurologic Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): HHV-7 Finding in Cerebrospinal Fluid Challenges Diagnostic Criteria
por: Sundholm, Anna, et al.
Publicado: (2023)

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2020)

Accurate classification of secondary progression in multiple sclerosis using a decision tree
por: Ramanujam, Ryan, et al.
Publicado: (2020)

Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study
por: Song, Jie, et al.
Publicado: (2018)

Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy
por: Han, Jinming, et al.
Publicado: (2020)

Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
por: He, Anna, et al.
Publicado: (2023)

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
por: Han, Jinming, et al.
Publicado: (2022)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2022)

Cerebrospinal fluid in multiple sclerosis
por: Rammohan, Kottil W.
Publicado: (2009)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
por: Martínez, M Alba Mañé, et al.
Publicado: (2015)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
por: Binzer, Stefanie, et al.
Publicado: (2019)

Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
por: Bruijstens, Arlette L, et al.
Publicado: (2022)

Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review
por: McKay, Kyla A., et al.
Publicado: (2015)

Four Swedish cases of CSF1R‐related leukoencephalopathy: Visualization of clinical phenotypes
por: Rosenstein, Igal, et al.
Publicado: (2022)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
por: McKay, Kyla A., et al.
Publicado: (2022)

Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
por: He, Anna, et al.
Publicado: (2023)

Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
por: He, Anna H, et al.
Publicado: (2023)

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden
por: McKay, Kyla A., et al.
Publicado: (2021)

Establishing a Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic: Baseline Clinical Features of the Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort at Karolinska Institutet
por: Gromark, Caroline, et al.
Publicado: (2019)

Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers
por: Everest, Elif, et al.
Publicado: (2023)

Administrative data for observational research in multiple sclerosis: Opportunities and challenges
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis
por: Ehling, Rainer, et al.
Publicado: (2011)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Cerebrospinal fluid GAP-43 in early multiple sclerosis
por: Rot, U, et al.
Publicado: (2018)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
por: Lo Sasso, Bruna, et al.
Publicado: (2019)

The cerebrospinal fluid in multiple sclerosis: far beyond the bands
por: Domingues, Renan Barros, et al.
Publicado: (2017)

Cerebrospinal fluid cells immune landscape in multiple sclerosis
por: Li, Zijian, et al.
Publicado: (2021)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis
por: Callegari, Ilaria, et al.
Publicado: (2023)

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023)

Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
por: Skinningsrud, Anders, et al.
Publicado: (2008)

Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid
por: Kaushik, Deepak K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a5la0brhad0udr2ru6bjv7lu48